Nicotinamide adenine dinucleotide — NAD+ — is one of the most-studied small molecules in cell biology, and one of the most frequently oversimplified. It appears in metabolism textbooks as a hydrogen shuttle, in longevity papers as a substrate that declines with age, and in supplement marketing as something considerably more than either. This article is an educational overview of what the research literature actually investigates: NAD+'s dual role in the cell, the enzymes that consume it, how cells replenish it, and what remains genuinely unresolved. Cerberus Research Labs supplies compounds strictly for laboratory research use — this is not dosing guidance, not medical advice, and nothing here is intended for human or veterinary use.
Two jobs, one molecule
NAD+ does two structurally related but functionally distinct things, and conflating them is the source of most confusion in this area.
- As a redox coenzyme, NAD+ accepts a hydride ion to become NADH, ferries those electrons, and is regenerated back to NAD+. This is the role in glycolysis, the citric acid cycle, and fatty-acid oxidation, feeding electrons into the mitochondrial electron transport chain. Critically, this role is catalytic — the molecule cycles between NAD+ and NADH indefinitely and is not consumed.
- As a signaling substrate, NAD+ is cleaved and destroyed. Sirtuins, PARPs, and CD38/CD157 all break the glycosidic bond in NAD+ to do their work, releasing nicotinamide as a byproduct. This role is consumptive — every deacetylation event a sirtuin performs costs the cell one NAD+ molecule.
Because the consumptive arm draws continuously on the same pool the redox arm depends on, cells must synthesize NAD+ on an ongoing basis. That competition between energy metabolism and signaling is the mechanistic backdrop for most NAD+ research.
The enzymes that spend it
Three enzyme families dominate NAD+ consumption in the research literature, and each maps to a different research question:
- Sirtuins (SIRT1-7) — NAD+-dependent deacylases studied in the context of transcriptional regulation, mitochondrial biogenesis, and metabolic adaptation. Their strict NAD+ dependence is why sirtuin activity is often framed as a sensor of cellular energy state in research models.
- PARPs — poly(ADP-ribose) polymerases, activated primarily by DNA damage. PARP1 in particular is studied as a heavy NAD+ consumer under genotoxic stress, and the research question of interest is whether sustained DNA-damage signaling draws down the NAD+ pool available for other processes.
- CD38 — an NAD+-consuming ectoenzyme studied in the context of immune signaling and inflammation. CD38 expression has been reported to increase in aged tissue in research models, making it a recurring subject in work on age-associated NAD+ decline.
The salvage pathway — how cells refill the pool
Mammalian cells synthesize NAD+ by several routes, but the dominant one under normal conditions is the salvage pathway, which recycles the nicotinamide released by sirtuins, PARPs, and CD38 back into NAD+. The rate-limiting step is NAMPT (nicotinamide phosphoribosyltransferase), which converts nicotinamide to nicotinamide mononucleotide (NMN); NMNAT enzymes then convert NMN to NAD+. Nicotinamide riboside (NR) enters the same pathway one step downstream via NRK kinases. A separate de novo route builds NAD+ from tryptophan through the kynurenine pathway, and the Preiss-Handler pathway starts from nicotinic acid.
The reason NAD+ precursors — rather than NAD+ itself — dominate the research literature is a transport problem, not a preference. Intact NAD+ is a large, charged dinucleotide that does not readily cross the plasma membrane, so what reaches the intracellular pool after extracellular NAD+ is introduced remains an active question in research models.
Age-associated decline: what is reported, and what isn't settled
A consistent observation across research models is that tissue NAD+ levels decline with age. Where the literature is genuinely unsettled is why, and what follows from it. Proposed contributors include increased consumption by CD38 and by chronically activated PARPs, reduced NAMPT expression, and altered circadian regulation of the salvage pathway — and these are not mutually exclusive. Whether restoring NAD+ levels in a research model reverses functional decline, or merely correlates with it, is exactly the kind of question the current work is designed to separate. Reported associations in animal or cell models should not be read as established outcomes, and certainly not as human results.
Adjacent research compounds
Several other compounds in the mitochondrial and cellular-energy research space appear alongside NAD+ in the literature for mechanistically distinct reasons:
- MOTS-c — a mitochondrial-derived peptide encoded in mitochondrial DNA, studied for its reported involvement in AMPK signaling and metabolic regulation in research models.
- SS-31 — a mitochondria-targeting tetrapeptide studied for its association with the inner mitochondrial membrane phospholipid cardiolipin, a structural rather than substrate-level line of inquiry.
- 5-Amino-1MQ — studied as an NNMT inhibitor. NNMT methylates nicotinamide and diverts it away from the salvage pathway, which is why NNMT inhibition is investigated in the context of NAD+ pool dynamics.
These sit in the same research neighborhood but are not interchangeable, and grouping them under a single "energy" heading obscures the mechanisms that make each one interesting to study. The full research catalog lists each with its lot documentation.
Handling notes for the bench
NAD+ is a nucleotide rather than a peptide, and its handling profile reflects that. Research-grade material is typically supplied lyophilized and stored cold; NAD+ in aqueous solution is known to be sensitive to elevated pH and temperature, which is why solutions are generally prepared close to the point of use rather than stored long-term. Our free reconstitution calculator handles the concentration arithmetic once a diluent volume is chosen, and the general storage principles covered in our overview of peptide stability and the cold chain — minimize freeze-thaw cycling, limit light exposure, reconstitute only what a near-term protocol requires — apply here as well. Lot-specific documentation in the COA library should always take precedence over general guidance.
The honest read
NAD+ biology is well characterized at the level of enzymology and comparatively unresolved at the level of intervention. That the molecule is essential to redox metabolism is textbook; that its tissue levels decline with age is widely reported in research models; what raising those levels does functionally, by what route, and in what tissue, is the open work. Treating the first two facts as if they establish the third is the most common error in how this literature gets summarized.
Research use only. Every compound referenced here is supplied for laboratory research purposes only. Nothing in this article is medical advice, and none of these materials are for human or veterinary use, diagnosis, treatment, or consumption.